{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:45:20Z","timestamp":1791265520256,"version":"4.1.0"},"reference-count":32,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,7,7]],"date-time":"2008-07-07T00:00:00Z","timestamp":1215388800000},"content-version":"vor","delay-in-days":2836,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Transplantation"],"published-print":{"date-parts":[[2000,10]]},"abstract":"<jats:p>In order to determine risk factors for bone loss after renal transplantation, dual energy X\u2010ray absorptiometry was performed in 125 renal transplant patients. The bone mineral density (BMD) was expressed as a percentage of the normal population (BMD%) and Z\u2010score (SD from normal). The whole body, lumbar spine and femoral neck BMD% (Z\u2010score) values were 93.9\u00b18.9 (\u22120.90 SD), 91.6\u00b114.9 (\u22120.98 SD) and 87\u00b115.3 (\u22121.0 SD)%, respectively. Low BMD% was associated with low creatinine clearance (&lt;40 mL\/min: 91.6\u00b17.9, &gt;40 mL\/min: 95.6\u00b18.0, p&lt;0.01), repeated graft loss (0: 94.4\u00b19.1, &gt;1: 87.4\u00b19.3, p&lt;0.05), long dialysis duration (&lt;1 yr: 95.2\u00b17.9, &gt;5: 90.1\u00b110.6, p&lt;0.05), acidosis (bicarbonate &lt;21 mmol\/L: 89.6\u00b18.0, &gt;27: 96.7\u00b17.2, p&lt;0.01), secondary and tertiary hyperparathyroidism (&lt;50 ng\/L: 95.9\u00b17.1, &gt;200: 87.7\u00b15.0, p&lt;0.01), raised alkaline phosphatase (&lt;200 units\/L: 95.7\u00b17.2, &gt;300: 85.6\u00b113.2, p&lt;0.001), osteocalcin (&lt;50 \u03bcg\/L: 95.2\u00b16.7, &gt;100: 89.3\u00b17.6, p&lt;0.01) and urinary deoxypyridinoline (&lt;5 nM\/mM creatinine: femoral neck 89.6\u00b110.7, &gt;10: 82.1\u00b120.1, p&lt;0.05), low 25\u2010OH\u2010vitamin D (&lt;10 \u03bcg\/L: 91.3\u00b19.8, &gt;20: 96.9\u00b17.4, p&lt;0.001) and high cyclosporine concentration (0 ng\/L: 98.3\u00b17.0, &gt;150: 92.1\u00b19.3, p&lt;0.05). Patients with clinical atherosclerosis (91.7\u00b18.6 vs. 95.4\u00b18.8, p&lt;0.01), hypoalbuminemia (&lt;550 \u03bcmol\/L: 87.6\u00b113.2, &gt;550: 94.2\u00b17.8, p&lt;0.01), renovascular disease (89.7\u00b15.7 vs. 95.0\u00b15.7, p&lt;0.05) and diabetic nephropathy (femoral neck 76.6\u00b18.8 vs. 89.3\u00b115.1, p&lt;0.01) had lower bone masses. High bone mass was associated with previous dialysis alphacalcidol therapy (0: 92.2\u00b17.5, &gt;3 \u03bcg\/wk: 97.3\u00b16.9, p&lt;0.05). No relationships with transplantation duration, 1,25\u2010OH\u2010vitamin D, aluminium, calcium or steroid dose were found. No involutional changes in tertiary hyperparathyroidism could be discerned. \u2028Conclusion. The major threats to bone mass after renal transplantation appear to be ongoing hyperparathyroid bone disease, low renal function, acidosis, systemic disease and hypo\u2010vitaminosis D.<\/jats:p>","DOI":"10.1034\/j.1399-0012.2000.140503.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T13:46:58Z","timestamp":1047390418000},"page":"457-463","source":"Crossref","is-referenced-by-count":80,"title":["Bone loss after renal transplantation: role of hyperparathyroidism, acidosis, cyclosporine and systemic disease"],"prefix":"10.1111","volume":"14","author":[{"given":"James","family":"Heaf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erling","family":"Tvedegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge\u2010Lis","family":"Kanstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Fogh\u2010Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,7,7]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1259\/0007-1285-46-547-548"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002239900051"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1177\/000456329703400606"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(75)92736-1"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)91862-4"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-123-5-2571"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/jor.1100080503"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198307000-00027"},{"key":"e_1_2_5_10_2","first-page":"950","article-title":"Cyclosporine A and prednisone\u2010associated osteoporosis in heart transplant recipients","volume":"11","author":"Rich GM","year":"1992","journal-title":"J Heart Lung Transplant"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(00)00833-2"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199702150-00009"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199412150-00008"},{"key":"e_1_2_5_14_2","first-page":"203","article-title":"Parathyroid hormone during maintenance dialysis: influence of low calcium dialysate, plasma albumin and age","volume":"11","author":"Heaf JG","year":"1998","journal-title":"J Nephrol"},{"key":"e_1_2_5_15_2","first-page":"389","article-title":"The effect of oral 1\u03b1\u2010hydroxycalciferol treatment on bone mineral density in hemodialysis patients","volume":"46","author":"Morita A","year":"1996","journal-title":"Clin Nephrol"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000186639"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1159\/000185644"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90129-3"},{"key":"e_1_2_5_19_2","first-page":"333","article-title":"Hypophosphatemia in long\u2010term renal transplant recipients: effects on bone histology and 1,25\u2010dihydroxycholecalciferol","volume":"12","author":"Felsenfeld AJ","year":"1986","journal-title":"Miner Electrolyte Metab"},{"key":"e_1_2_5_20_2","first-page":"206","article-title":"Absence of effect of 24,25\u2010dihydroxycholecalciferol on serum immunoreactive PTH in patients with persistent hyperparathyroidism after renal transplantation","volume":"22","author":"Friedlander MA","year":"1984","journal-title":"Clin Nephrol"},{"key":"e_1_2_5_21_2","first-page":"70","article-title":"Viatamin D3 metabolites in chronic renal failure and after renal transplantation","volume":"3","author":"Lucas PA","year":"1988","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199505270-00006"},{"issue":"62","key":"e_1_2_5_23_2","first-page":"S90","article-title":"Atherosclerosis in uremia: possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation","volume":"52","author":"Nishizawa Y","year":"1977","journal-title":"Kidney Int"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-978760"},{"key":"e_1_2_5_25_2","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1681\/ASN.V8101553","article-title":"Bone density and skeletal metabolism in patients with orthotropic ileal neobladder","volume":"8","author":"Giannini S","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406233302502"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199504150-00010"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(96)90138-9"},{"key":"e_1_2_5_29_2","first-page":"2646","article-title":"Bone mineral content in cyclosporine\u2010treated renal transplant patients","volume":"26","author":"Massari PU","year":"1994","journal-title":"Transplantation Proc"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199108223250804"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-112-5-352"},{"key":"e_1_2_5_32_2","unstructured":"Rix M. Metabolic bone disease in patients with predialysis chronic renal failure. Ph.D. Thesis University of Copenhagen 1999: 29\u201332."},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199310000-00013"}],"container-title":["Clinical Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-0012.2000.140503.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-0012.2000.140503.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1399-0012.2000.140503.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T14:25:04Z","timestamp":1698589504000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1399-0012.2000.140503.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,10]]}},"alternative-id":["10.1034\/j.1399-0012.2000.140503.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1399-0012.2000.140503.x","archive":["Portico"],"relation":{},"ISSN":["0902-0063","1399-0012"],"issn-type":[{"value":"0902-0063","type":"print"},{"value":"1399-0012","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,10]]}}}